Ending the year in debate

Article

The holiday season is upon us again and we are about to close the door on another year, but before we do, I would firstly like to say a big thank you to all of you for your continued support of our publication throughout this year.

The holiday season is upon us again and we are about to close the door on another year, but before we do, I would firstly like to say a big thank you to all of you for your continued support of our publication throughout this year. The OTE team and I have really enjoyed working with you and meeting with you while we've been out and about, and we look forward to doing so in 2009.

But before we say goodbye to 2008, we have a real treat in store for you. We are ending the year with a series of debates on some of the most controversial topics in ophthalmology. The 2008 debates series raises important issues that made it to the podium this year. So have a look at our debates to read what some of the world's eminent surgeons had to say when they came head-to-head on some of the most important issues in your industry.

On a separate note, I would like to take this opportunity to announce that we are about to have a facelift! Yes, the first issue of OTE in 2009 will have a new look. We're going for a new size issue that will be packed with more content than before. We've also changed our weekly e-newsletter, which will be going out on Wednesdays rather than Mondays. If you've not subscribed already, just go to www.oteurope.com/enews to take advantage of this free, weekly breaking news service. We hope you like the changes. As always, I would be really happy to hear your thoughts so please do drop me an email to let me know what you think.

Thank you once again for another great year. Let's enter 2009 with optimism and hope for continued successes. I know I will!

Happy holidays everyone.

Best wishes,

Fedra Pavlou
Editor
fpavlou@advanstar.com

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.